Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 41, Issue 8, 1998, Pages 1388-1397

  Hermann, Josef A ^a,b   Hall, Mark A ^c   Maini, Ravinder N ^b   Feldmann, Marc ^b   Brennan, Fionula M ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 11;

ARTICLE; DRUG USE; ENZYME REGULATION; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM;

ADJUVANTS, IMMUNOLOGIC; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CYTOKINES; DRUG INTERACTIONS; ENZYME INHIBITORS; FIBROBLASTS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-11; METALLOENDOPEPTIDASES; MONOCYTES; RECEPTORS, INTERLEUKIN; RECOMBINANT PROTEINS; SOLUBILITY; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031826987     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199808)41:8<1388::AID-ART7>3.0.CO;2-F     Document Type: Article

References (33)

1. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
2. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
3. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994;179:1517-27.
4. Brennan FM, Gibbons D, Cope A, Katsikis P, Maini RN, Feldmann M. TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic synovial joint cell cultures: evidence of feedback control of TNF action. Scand J Immunol 1995;421:158-65.
5. Firestein GS, Berger AE, Tracey DE, Chosay JG, Chapman DL, Paine MM, et al. IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 1992;149:1054-62.
6. Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, et al. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 1988;18:1797-801.
7. Wahl SM, Allen JB, Wong HL, Dougherty SF, Ellingsworth LR. Antagonistic and agonistic effects of transforming growth factor-beta and IL-1 in rheumatoid synovium. J Immunol 1990;145: 2514-9.
8. Paul SR, Bennett F, Calvetti JA, Kelleher K, Wood CR, O'Hara RM Jr, et al. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci U S A 1990;87:7512-6.
9. Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995;86:1243-54.
10. Du XX, Williams DA. Interleukin-11: a multifunctional growth factor derived from the hematopoietic microenvironment. Blood 1994;83:2023-30.
11. Gordon MS, McCaskill-Stevens WJ, Bittiato LA, Loewy J, Liesch D, Breeden E, et al. A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 1996;87:3615-24.
12. Yin T, Taga T, Tsang ML, Yasukawa K, Kishimoto T, Yang YC. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J Immunol 1993;151:2555-61.
13. Neddermann P, Graziani R, Ciliberto G, Paonessa G. Functional expression of soluble human interleukin-11 (IL-11) receptor a and stoichiometry of in vitro IL-11 receptor complexes with gp130. J Biol Chem 1996;271:30986-91.
14. Cherel M, Sorel M, Lebeau B, Dubois S, Moreau JF, Bataille R, et al. Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11. Blood 1995;86: 2534-40.
15. Karow J, Hudson KR, Hall MA, Vernallis AB, Taylor JA, Gossler A, et al. Mediation of interleukin-11-dependent biological responses by a soluble form of the interleukin-11 receptor. Biochem J 1996;318:489-95.
16. Baumann H, Wang Y, Morella KK, Lai C-F, Dams H, Hilton DJ, et al. Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cells. J Immunol 1996;157:284-90.
17. Yin TG, Schendel P, Yang YC. Enhancement of in vitro and in vivo antigen-specific antibody responses by interleukin 11. J Exp Med 1992;175:211-6.
18. Trepicchio WL, Bozza M, Pedneault G, Dorner AJ. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol 1996;157:3627-34.
19. Redlich CA, Gao X, Rockwell S, Kelley M, Elias JA. IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol 1996;157:1705-10.
20. Maier R, Ganu V, Lotz M. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem 1993;268:21527-32.
21. Girasole G, Passeri G, Jilka RL, Manolagas SC. Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 1994;93:1516-24.
22. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
23. Brennan FM, Chantry D, Turner M, Foxwell B, Maini RN, Feldmann M. Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: lack of effect on spontaneous cytokine production in joint cell cultures. Clin Exp Immunol 1990;81:278-85.
24. Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M. Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989;2:244-7.
25. Engelberts I, Moller A, Schoen GJM, van der Linden CJ, Buurman WA. Evaluation of human TNF in plasma by ELISA. Lymphokine Cytokine Res 1991;10:60-76.
26. Abrams JS, Roncarolo M-G, Yssel H, Andersson U, Gleich GJ, Silver J. Strategies and practice of anti cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 1992;127:5-24.
27. Lu ZY, Zhang XG, Gu ZJ, Yasukawa K, Amiot M, Etrillard M, et al. A highly sensitive quantitative bioassay for human interleukin-11. J Immunol Methods 1994;173:19-26.
28. Butler DM, Maini RN, Feldmann M, Brennan FM. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures: comparison of anti-TNFα antibody with the IL-1 receptor antagonist. Eur Cytokine Netw 1995;6:225-30.
29. Williams RO, Mason LJ, Feldmann M, Maini RN. Synergy between anti-CD4 and anti-TNF in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci U S A 1994;91: 2762-6.
30. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α. Lancet 1994;344: 1105-10.
31. Dechanet J, Taupin J-L, Chomarat P, Rissoan M-C, Moreau J-F, Banchereau J, et al. Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur J Immunol 1994;24:3222-8.
32. Vincenti MP, Clark IM, Brinckerhoff CE. Using inhibitors of metalloproteinases to treat arthritis: easier said than done? Arthritis Rheum 1994;37:1115-26.
33. Walmsley M, Butler DM, Marinova-Mutafchieva L, Feldmann M. An anti-inflammatory role for interleukin 11 in established collagen-induced arthritis. Immunology. In press.